The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Brand Name :
Acetadote, N-acetylcysteine (Antidote), Cetylev
Synonyms :
acetylcysteine
Class :
Antidotes, Other
Dosage Forms & StrengthsÂ
injectable solutionÂ
200mg/mL (20%)Â
effervescent tablets for the oral solution (Cetylev)Â
2.5g (DSC)Â
500mg (DSC)Â
Orally administer injectable
Continuous Intravenous infusion is advised for acute ingestion (preferably within 8-10 hours of ingestion but may be administered if more than 10 hours)
Intermittent Intravenous infusion may be recommended for chronic ingestion or late presenting (more than 10 hours after the ingestion)
Orally administer injectable
140 mg/kg orally as a loading dose
Maintenance dose: 4 hours after the loading dosage, administer 70 mg/kg orally every 4hours for a total of 17 doses; repeat dosage if emesis occurs within the 1 hour of administration
Intravenous continuous infusion
Acute intake (within 8-10 hours after ingestion)
3 doses should be administered
Loading dose: 150 mg/kg intravenous, followed by 200 mL of D5W infusion over 1 hour
Dosage 2: 50 mg/kg Intravenous in 500 mL D5W over 4 hours
Dosage 3: 100 mg/kg Intravenous in 1000 mL D5W over 16 hours
More than 100 kg: There have been no studies; A loading dosage of 15,000 mg injected Intravenous over 1 hour, followed by a first maintenance dose of 5,000 mg intravenous over 4 hours and then a second maintenance dosage of 10,000 mg over 16 hours, according to limited data
Intermittent Intravenous administration (off-label)
The Total therapy time: 48 hours
chronic ingestion or Late presenting (more than 10 hours after ingestion) in patients with more than 40 kg
140 mg/kg Intravenous given over 1 hr (diluted in 500 mL of D5W) as loading dose, following
Maintenance dose: 70 mg/kg intravenous every 4 hours for at least 12 doses (Each dosage should be diluted in 250 mL of D5W and infused for at least 1 hour)
Dosage Forms & StrengthsÂ
injectable solutionÂ
200mg/mL (20%)Â
effervescent tablets for the oral solution (Cetylev)Â
2.5g (DSC)Â
500mg (DSC)Â
Orally administer injectable
Continuous intravenous infusion is advised for acute ingestion (preferably within 8-10 hours of ingestion but may be administered if more than 10 hours)
Intermittent intravenous infusion may be recommended for chronic ingestion or late presenting (more than 10 hours after the ingestion)
Orally administration
140 mg/kg orally as a loading dose
Maintenance dose: 4 hours after the loading dosage, administer 70 mg/kg orally every 4hours for a total of 17 doses; repeat dosage if emesis occurs within the 1 hour of administration
below 20 kg Intravenous continuous infusion (Acetadote)
150 mg/kg intravenous in 3 mL diluent/kg of body weight given over 1 hour as Loading dose
Dosage 2: 50 mg/kg intravenous in 7 mL diluent/kg of body weight administered over 4-hours
Dosage 3: 100 mg/kg in 14 mL diluent/kg of body weight administered over 16-hours
Above 20 kg to below 40 kg Intravenous continuous infusion (Acetadote)
150 mg/kg Intravenous in 100 mL of diluent given over 1 hour as loading Dose
Dosage 2: 50 mg/kg Intravenous in 250 mL of diluent given over 4 hours
Dosage 3: 100 mg/kg Intravenous in 500 mL of diluent given over 16 hours
Weight more than 40 kg for Intravenous continuous infusion (Acetadote)
As adults
150 mg/kg Intravenous; combine in 200 mL of the D5W and then infuse for 1 hour as loading dose
Dosage 2: 50 mg/kg Intravenous over 4 hours in 500 mL D5W, following
Dosage 3: 100 mg/kg Intravenous in 1000 mL D5W administered over 16 hours
Intermittent infusion (Off-label)
The Total therapy time: 48 hours
chronic ingestion or Late presenting (more than 10 hours after ingestion) in patients with more than 40 kg
A Loading dose: 140 mg/kg Intravenous given over 1 hr (diluted in 500 mL of D5W), following
Maintenance dose: 70 mg/kg intravenous every 4 hours for at least 12 doses (Each dosage should be diluted in 250 mL of D5W and infused for at least 1 hour)
Refer to the adult dosing regimenÂ
Actions and spectrum:Â
acetylcysteine is an antidote that acts as a precursor of glutathione, a molecule that helps neutralize toxic substances in the body. It is primarily used to treat acetaminophen (paracetamol) overdose, a common cause of liver failure.
acetylcysteine can also treat other types of poisoning, such as carbon monoxide poisoning, and loosen thick mucus in conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).Â
Frequency not definedÂ
IV administrationÂ
Oral administrationÂ
Contraindication/Caution:Â
Contraindication:Â
acetylcysteine is contraindicated in individuals with a known hypersensitivity to acetylcysteine or any component of the formulation. It should also be used under caution in individuals with asthma, bronchospasm, or a history of peptic ulcer disease. Â
Caution:Â
Comorbidities:Â
acetylcysteine is generally well-tolerated, and there are no specific comorbidities that preclude its use as an antidote. However, it should be used under caution in patients with bronchospasm or asthma, as acetylcysteine may exacerbate these conditions.
Additionally, acetylcysteine may interact with other medications, so it is important to review a patient’s medication history prior to administration.
In patients with liver disease, acetylcysteine should be used with caution, as it may worsen hepatic encephalopathy. Finally, acetylcysteine should not be administered to patients with a known hypersensitivity to the drug.Â
Pregnancy consideration: Pregnancy Category BÂ
Lactation: acetylcysteine is excreted in breast milk, so caution should be exercised if it is used during lactation. Â
Pregnancy category:Â
Pharmacology:Â
acetylcysteine is a mucolytic agent that works by breaking down the disulfide bonds that are responsible for mucus viscosity. acetylcysteine is also a precursor to glutathione, a potent antioxidant that is essential for maintaining the cellular redox balance. In overdose situations, acetylcysteine is used as an antidote for acetaminophen poisoning.
acetylcysteine replenishes the depleted hepatic glutathione stores, thereby preventing the formation of toxic metabolites that cause liver injury. acetylcysteine is also used in the treatment of other pulmonary disorders, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and bronchitis. Â
Pharmacodynamics:Â
acetylcysteine is a mucolytic agent that works by breaking disulfide bonds in mucus, resulting in decreased viscosity and improved clearance of respiratory secretions. As an antidote, it works by replenishing depleted glutathione stores in the liver and reducing the toxicity of reactive metabolites of acetaminophen.Â
acetaminophen is a common analgesic and antipyretic medication, but when taken in large doses, it can cause hepatotoxicity due to the formation of toxic metabolites. acetylcysteine acts as an antidote to acetaminophen overdose by increasing the availability of glutathione, which binds to and neutralizes the toxic metabolites. It also provides an alternate pathway for the elimination of toxic metabolites and reduces the formation of additional toxic metabolites. Â
Pharmacokinetics:Â
AbsorptionÂ
acetylcysteine is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1-2 hours. The absolute bioavailability of oral acetylcysteine is low, at approximately 10%. After intravenous administration, acetylcysteine is rapidly and completely distributed throughout the body.Â
DistributionÂ
acetylcysteine has a volume of distribution of approximately 0.47 L/kg, indicating that it is widely distributed throughout the body. It readily crosses the placenta and is distributed into breast milk.Â
MetabolismÂ
acetylcysteine undergoes rapid and extensive metabolism in the liver, where it is deacetylated to cysteine and subsequently metabolized to other sulfur-containing compounds.Â
Elimination and excretionÂ
acetylcysteine and its metabolites are excreted primarily in the urine, with approximately 13% of a dose being excreted unchanged within the first 24 hours after administration. The terminal elimination half-life of acetylcysteine is approximately 5.6 hours.Â
Administration:Â
acetylcysteine is available in different forms for administration, including oral, inhalation, and intravenous routes. The route of administration and dosing may vary depending on the condition being treated. For example, in the treatment of acetaminophen overdose, oral or intravenous acetylcysteine is usually administered.
The oral dose of acetylcysteine for this purpose is typically given as a loading dose followed by maintenance doses over the next 20-72 hours. The intravenous formulation of acetylcysteine is administered as a single dose over 15 minutes, followed by a second dose over 4 hours and a third dose over 16 hours.Â
In the treatment of respiratory conditions, acetylcysteine may be given by inhalation. The recommended dose for inhalation of acetylcysteine is usually 1-2 ampules per day, administered using a nebulizer or other inhalation device.Â
Patient information leafletÂ
Generic Name: acetylcysteineÂ
Pronounced: [ a-SEET-il-SIS-teen]Â Â
Why do we use acetylcysteine (Antidote)?Â
acetylcysteine is primarily used as an antidote for acetaminophen overdose, which is a common cause of acute liver failure. It is also used to thin mucus in the respiratory tract, making it easy to cough up, and it is used to treat conditions like chronic obstructive pulmonary disease, cystic fibrosis, and bronchitis.
acetylcysteine is also sometimes used as a treatment for certain types of kidney stones and to protect the kidney damage caused by certain diagnostic tests or medications. In addition, it may be used to reduce the risk of contrast-induced nephropathy, a type of kidney damage that can occur after certain medical procedures involving the use of contrast agents.Â